Literature DB >> 11738074

Separation and characterization of the molecular species of thrombomodulin in the plasma of diabetic patients.

S Uehara1, K Gotoh, H Handa.   

Abstract

Thrombomodulin (TM) and its molecular species have been identified as markers of vascular endothelial cells (EC). In the present study, using high-performance liquid chromatography (HPLC) in 7 normal subjects, 5 chronic glomerulonephritis (GN) patients, and 25 diabetes mellitus (DM) patients, the TM molecular species separated from plasma showed seven heterogeneous fragments of 94, 74, 48, 36, 27, 14, and 12 kDa. Comparing the diabetic patients and healthy subjects, it was found that plasma TM generally, and its 74-kDa molecular species particularly, were increased in diabetic patients and the increase became more apparent as the disease progressed in severity. Comparing the patients with diabetic nephropathy and those with nephritis of the same degree of renal dysfunction, both groups had increased levels of TM, but the distribution of the molecular species differed; that is, the 74-kDa form increased in the diabetic patients and the 12-kDa species increased markedly in the nephritis patients. Glycation of the various TM molecular species increased more in the diabetic patients than in healthy subjects. There was a significantly positive correlation between the HbA(1c) and the 74-kDa TM molecular species in diabetic patients. These findings suggest that a fluctuation in the blood glucose level is significantly related to vascular EC damage in DM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738074     DOI: 10.1016/s0049-3848(01)00358-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-1998.

Authors:  B Thorand; J Baumert; C Herder; C Meisinger; W Koenig
Journal:  Diabetologia       Date:  2006-12-29       Impact factor: 10.122

2.  Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis.

Authors:  Shun-Min Yang; Shuk-Man Ka; Hua-Lin Wu; Yu-Chuan Yeh; Cheng-Hsiang Kuo; Kuo-Feng Hua; Guey-Yueh Shi; Yi-Jen Hung; Fone-Ching Hsiao; Sung-Sen Yang; Yi-Shing Shieh; Shih-Hua Lin; Chyou-Wei Wei; Jeng-Shin Lee; Chu-Yi Yang; Ann Chen
Journal:  Diabetologia       Date:  2013-11-30       Impact factor: 10.122

Review 3.  Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

Authors:  Mallorie Boron; Tiffany Hauzer-Martin; Joseph Keil; Xue-Long Sun
Journal:  TH Open       Date:  2022-07-11

4.  Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation-A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients.

Authors:  Michael Hultström; Karin Fromell; Anders Larsson; Barbro Persson; Bo Nilsson; Susan E Quaggin; Christer Betsholtz; Robert Frithiof; Miklos Lipcsey; Marie Jeansson
Journal:  Biomedicines       Date:  2022-06-06

5.  Endothelial dysfunction in geriatric diabetic patients: the role of microalbuminuria in elderly type 2 diabetic patients? A randomized controlled study.

Authors:  Mohamed A Helaly; Hussein A Sheashaa; El Sayed Z Hatata; Ansaf B Youssef; Asmaa Hegazi; Ibrahim A Abdel-Aal
Journal:  Int Urol Nephrol       Date:  2006-09-20       Impact factor: 2.266

Review 6.  Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.

Authors:  Takashi Ito; Jecko Thachil; Hidesaku Asakura; Jerrold H Levy; Toshiaki Iba
Journal:  Crit Care       Date:  2019-08-15       Impact factor: 9.097

7.  Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways.

Authors:  Trai-Ming Yeh; Shu-Hsiang Liu; Kao-Chang Lin; Chieh Kuo; Shu-Yun Kuo; Tzuu-Yuan Huang; Yong-Ren Yen; Rong-Kun Wen; Lien-Cheng Chen; Tsai-Feng Fu
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.